Evolutions in the Management of Advanced Ovarian Cancer (Ongoing)

Posted On 2020-07-09 07:59:23

This special series on “Evolutions in the Management of Advanced Ovarian Cancer” is edited by Dr. Hooman Soleymani Majd, MD, MRCOG, BSCCP, from Department of Gynaecologic Oncology, Oxford University Hospital NHS Trust, Churchill Hospital, Oxford, UK.

Hooman Soleymani Majd, MD, MRCOG, BSCCP
Department of Gynaecologic Oncology, Oxford University Hospital NHS Trust, Churchill Hospital, Oxford, UK

Dr. Hooman Soleymani Majd is a Consultant gynaecological oncology surgeon, based at the Churchill cancer centre in Oxford. He is the clinical governance lead for the gynaecology oncology department and is a BSCCP accredited colposcopist and trainer. He has active involvement in teaching registrars/fellows and medical students from Oxford University and has been a faculty member and demonstrator for a number of years at the annual BSGE Cadaveric dissection course. He is part of an Oxford research group that has a special interest in developing new surgical techniques in ultra-radical surgery for advanced ovarian cancer.

Dr. Soleymani Majd is an accomplished and experienced advanced laparoscopic surgeon. He performs complex radical laparoscopic surgeries for uterine and cervical cancer. He also has a special interest in performing ultra-radical surgery for ovarian cancer and pelvic exenterative surgery. His skill set includes upper abdominal surgery, liver mobilization and diaphragmatic reconstruction. He also has a particular surgical interest in treating patients with abnormally invasive placenta’s (AIP).

Series outline:

  1. Editorial
  2. The role of immunotherapy in ovarian cancer 
  3. The role of minimal access surgery in management of early stage ovarian cancer 
  4. Radical pelvic cytoreductive surgery : the principles of en-bloc approach 
  5. Novel chemotherapeutic agents in management of ovarian cancer 
  6. The challenges in ovarian cancer relapse - the role of second and third line chemotherapy 
  7. The histological value of CRS in advanced ovarian cancer - histopathological challenges 
  8. The current role of imaging in the pre-operative management of ovarian cancer - the paradigm 
  9. The state of play with clinical trials for ovarian cancer     
  10. The role of exploratory laparoscopy as part of surgical planning for ultra-radical surgery for ovarian cancer 
  11. The principles of safe and efficacious upper abdominal surgery (including liver mobilization and splenectomy)
  12. The value of full thickness diaphragmatic surgery Vs diaphragmatic peritonectomy 
  13. The role of surgery in the management of ovarian cancer : beyond pelvis and abdomen  
  14. The role of multiple bowel resection in advanced ovarian cancer : survival and surgical outcome 
  15. The value of high quality post-operative care to minimize short and long term complications
The series “Evolutions in the Management of Advanced Ovarian Cancer” was commissioned by the editorial office, Gynecology and Pelvic Medicine without any sponsorship or funding. Hooman Soleymani Majd is serving as the unpaid Guest Editor for the series.